Literature DB >> 24099

Lithium inhibition of the adenosine-induced increase of adenylate cyclase activity.

R P Ebstein, A Reches, R H Belmaker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 24099     DOI： 10.1111/j.2042-7158.1978.tb13178.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  2 in total

1.  Release of norepinephrine from brain vesicular preparations: effects of an adenylate cyclase activator, forskolin, and a phosphodiesterase inhibitor.

Authors:  R P Ebstein; K Seamon; C R Creveling; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1982-09       Impact factor: 5.046

Review 2.  Molecular actions and clinical pharmacogenetics of lithium therapy.

Authors:  Adem Can; Thomas G Schulze; Todd D Gould
Journal:  Pharmacol Biochem Behav       Date:  2014-02-15       Impact factor: 3.533
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.